Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide

A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.

Detalles Bibliográficos
Autores principales: Hashimoto, Akiko, Tanaka, Yasuhiro, Shinzato, Isaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299272/
https://www.ncbi.nlm.nih.gov/pubmed/34322239
http://dx.doi.org/10.1002/ccr3.4300
_version_ 1783726236771549184
author Hashimoto, Akiko
Tanaka, Yasuhiro
Shinzato, Isaku
author_facet Hashimoto, Akiko
Tanaka, Yasuhiro
Shinzato, Isaku
author_sort Hashimoto, Akiko
collection PubMed
description A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.
format Online
Article
Text
id pubmed-8299272
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82992722021-07-27 Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide Hashimoto, Akiko Tanaka, Yasuhiro Shinzato, Isaku Clin Case Rep Case Report A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis. John Wiley and Sons Inc. 2021-07-23 /pmc/articles/PMC8299272/ /pubmed/34322239 http://dx.doi.org/10.1002/ccr3.4300 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Hashimoto, Akiko
Tanaka, Yasuhiro
Shinzato, Isaku
Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
title Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
title_full Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
title_fullStr Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
title_full_unstemmed Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
title_short Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
title_sort successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299272/
https://www.ncbi.nlm.nih.gov/pubmed/34322239
http://dx.doi.org/10.1002/ccr3.4300
work_keys_str_mv AT hashimotoakiko successfultreatmentofacutepromyelocyticleukemiainapatientundergoinghemodialysiswitharsenictrioxide
AT tanakayasuhiro successfultreatmentofacutepromyelocyticleukemiainapatientundergoinghemodialysiswitharsenictrioxide
AT shinzatoisaku successfultreatmentofacutepromyelocyticleukemiainapatientundergoinghemodialysiswitharsenictrioxide

Ejemplares similares